SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
85 hedge funds and large institutions have $141M invested in scPharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
-10
Holders Change %
-10.53%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
17
Increased
37
Reduced
16
Closed
26
Calls
$614K
Puts
$78K
Net Calls
+$536K
Net Calls Change
-$31K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$5.58M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.6M |
| 3 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
+$2.24M |
| 4 |
PA
Perceptive Advisors
New York
|
+$1.77M |
| 5 |
BlackRock
New York
|
+$1.52M |
Top Sellers
| 1 |
AIC
AWM Investment Company
New York
|
-$3.49M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.4M |
| 3 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$2.36M |
| 4 |
Walleye Capital
New York
|
-$2.17M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.46M |
